+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Graves Disease Market by Diagnosis, Treatment Type, Age Group, Route Of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Graves Disease Market by Diagnosis, Treatment Type, Age Group, Route Of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Graves Disease Market by Diagnosis, Treatment Type, Age Group, Route Of Administration, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674290
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Graves Disease Market is evolving rapidly, shaped by clinical innovation, regulatory dynamics, and shifting patient expectations. As healthcare systems prioritize effective management of chronic autoimmune conditions, this segment stands out for stakeholders aiming to optimize outcomes amid growing demand for advanced diagnostics and tailored therapies.

Market Snapshot: Graves Disease Market Growth Trends

From 2024 to 2025, the Graves Disease Market demonstrated resilient growth, progressing from USD 641.22 million to USD 677.20 million. The sector is projected to maintain a CAGR of 5.82%, with revenues anticipated to reach USD 900.53 million by 2030. These figures highlight a healthy expansion trajectory driven by heightened demand for reliable diagnostics, advanced therapies, and comprehensive patient care solutions worldwide.

Scope & Segmentation

  • Diagnosis Types: Blood tests (including free T4 & T3, TSH, and TSH-RAb), imaging tests (radioactive iodine uptake, thyroid ultrasound), and physical examinations all play a role in disease assessment.
  • Treatment Options: Choices encompass antithyroid medications, beta-blockers for symptom control, and radioactive iodine therapy for persistent cases.
  • Patient Age Groups: Solutions are tailored for adults, elderly individuals prioritizing safety, and pediatric patients needing adjusted regimens and monitoring.
  • Routes of Administration: Therapies are delivered via oral or intravenous formulations, depending on patient and care setting requirements.
  • Distribution Channels: Access is facilitated through hospital, online, and retail pharmacies—each offering distinct pathways for availability and patient support.
  • Geographic Regions: Analysis includes the Americas (United States, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (with major and emerging markets), and Asia-Pacific (China, India, Japan, and others invigorated by technology adoption and infrastructure investment).
  • Key Companies: Strategy, innovation, and market agility are observed across Abbott Laboratories, Novartis AG, Siemens Healthineers AG, Pfizer Inc., and other leading global and regional manufacturers, as well as collaborative biotech firms supporting diagnostic and therapeutic advancements.

Key Takeaways for Senior Decision-Makers

  • Diagnostic innovation remains central, with next-generation imaging and assay technologies enhancing detection speed and accuracy for Graves disease.
  • Personalized medicine is making measurable impacts through genetic profiling and biomarker-driven treatment, improving patient-specific efficacy and minimizing side effects.
  • Telemedicine and digital health applications are expanding long-term monitoring and adherence, particularly in outpatient and chronic care environments.
  • Multidisciplinary, patient-centric care models are becoming standard, with endocrinologists, pharmacists, and allied professionals collaborating for optimized outcomes.
  • Market segmentation underscores differentiated needs across age groups and care settings, influencing both product innovation and access strategies.
  • Collaborations between pharmaceutical manufacturers and diagnostic providers are accelerating integration of therapeutics and molecular imaging solutions, streamlining regulatory approval processes and care delivery pathways.

Tariff Impact on the Graves Disease Market

Recent U.S. tariff policies have disrupted supply chains by increasing the cost of imported iodine isotopes and pharmaceutical ingredients. This has led many providers and manufacturers to reevaluate procurement, pursue domestic sourcing, and deploy inventory buffering to maintain continuity of care. Smaller diagnostic labs and specialty clinics are most exposed to cost pressures, while larger players emphasize investment in local manufacturing to manage risks effectively.

Methodology & Data Sources

This report combines primary research—interviews with clinical and industry experts—and secondary sources, such as regulatory filings, literature reviews, and validated data sets from government and proprietary repositories. Results underwent rigorous triangulation and expert workshops to ensure accuracy and actionable insight.

Why This Report Matters

  • Enables strategic resource allocation by highlighting emerging trends, regulatory changes, and competitive dynamics in the Graves Disease Market.
  • Informs market entry, partnership, and product development decisions by providing granular segmentation, with actionable recommendations relevant across global regions.
  • Supports proactive responses to policy and supply chain disruptions, positioning stakeholders for resilience and sustainable growth.

Conclusion

This Graves Disease Market analysis provides a focused blueprint for decision-makers navigating a dynamic therapeutic landscape. Armed with integrated insights across technology, policy, and strategy, stakeholders are equipped to drive informed actions and achieve long-term value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Graves Disease Market, by Diagnosis
8.1. Introduction
8.2. Blood Tests
8.2.1. Free T4 & T3 Levels
8.2.2. Thyroid-stimulating Hormone (TSH) Levels
8.2.3. TSH Receptor Antibodies (TSH-RAb)
8.3. Imaging Tests
8.3.1. Radioactive Iodine Uptake
8.3.2. Thyroid Ultrasound
8.4. Physical Examination
9. Graves Disease Market, by Treatment Type
9.1. Introduction
9.2. Antithyroid Medications
9.3. Beta-Blockers
9.4. Radioactive Iodine Therapy
10. Graves Disease Market, by Age Group
10.1. Introduction
10.2. Adult
10.3. Elderly
10.4. Pediatric
11. Graves Disease Market, by Route Of Administration
11.1. Introduction
11.2. Intravenous
11.3. Oral
12. Graves Disease Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Americas Graves Disease Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Graves Disease Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Graves Disease Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. AdvanceCor GmbH
16.3.3. Cadila Pharmaceuticals Limited
16.3.4. CORONA Remedies Limited
16.3.5. Daxia Healthcare Pvt Ltd.
16.3.6. Eris Lifesciences Ltd
16.3.7. F. Hoffmann-La Roche Ltd.
16.3.8. Immunovant, Inc. by Roivant Sciences Ltd.
16.3.9. LGM Pharma
16.3.10. Macleods Pharmaceuticals Ltd.
16.3.11. Merck KGaA
16.3.12. Novartis AG
16.3.13. Pfizer Inc.
16.3.14. Salvavidas Pharmaceutical Pvt. Ltd.
16.3.15. Siemens Healthineers AG
16.3.16. Steris Healthcare Pvt Ltd
16.3.17. Sun Pharmaceutical Industries Ltd
16.3.18. Synmedic Laboratories by Dhanuka Laboratories Limited
16.3.19. Teva Pharmaceutical Industries Ltd.
16.3.20. Thermo Fisher Scientific Inc.
16.3.21. Wellona Pharma
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GRAVES DISEASE MARKET MULTI-CURRENCY
FIGURE 2. GRAVES DISEASE MARKET MULTI-LANGUAGE
FIGURE 3. GRAVES DISEASE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GRAVES DISEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GRAVES DISEASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GRAVES DISEASE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GRAVES DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GRAVES DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GRAVES DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GRAVES DISEASE MARKET SIZE, BY FREE T4 & T3 LEVELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GRAVES DISEASE MARKET SIZE, BY THYROID-STIMULATING HORMONE (TSH) LEVELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GRAVES DISEASE MARKET SIZE, BY TSH RECEPTOR ANTIBODIES (TSH-RAB), BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GRAVES DISEASE MARKET SIZE, BY THYROID ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GRAVES DISEASE MARKET SIZE, BY PHYSICAL EXAMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GRAVES DISEASE MARKET SIZE, BY ANTITHYROID MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GRAVES DISEASE MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GRAVES DISEASE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GRAVES DISEASE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GRAVES DISEASE MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GRAVES DISEASE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GRAVES DISEASE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GRAVES DISEASE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GRAVES DISEASE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GRAVES DISEASE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GRAVES DISEASE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES GRAVES DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. CANADA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 49. CANADA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 50. CANADA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 51. CANADA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 52. CANADA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 53. CANADA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. CANADA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. MEXICO GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 56. MEXICO GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 58. MEXICO GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 60. MEXICO GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. MEXICO GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. GERMANY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 92. GERMANY GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 93. GERMANY GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 94. GERMANY GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. GERMANY GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. GERMANY GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. FRANCE GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 99. FRANCE GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 100. FRANCE GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 101. FRANCE GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. FRANCE GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 103. FRANCE GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. FRANCE GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. RUSSIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. ITALY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 113. ITALY GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 114. ITALY GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 115. ITALY GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 116. ITALY GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 117. ITALY GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. ITALY GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. SPAIN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 120. SPAIN GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 121. SPAIN GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 122. SPAIN GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. SPAIN GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. SPAIN GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. SPAIN GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. DENMARK GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 148. DENMARK GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 149. DENMARK GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 150. DENMARK GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 151. DENMARK GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 152. DENMARK GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. DENMARK GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. QATAR GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 162. QATAR GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 163. QATAR GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 164. QATAR GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 165. QATAR GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 166. QATAR GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. QATAR GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. FINLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 169. FINLAND GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 170. FINLAND GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 171. FINLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 172. FINLAND GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 173. FINLAND GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. FINLAND GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. EGYPT GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 190. EGYPT GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 191. EGYPT GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 192. EGYPT GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 193. EGYPT GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 194. EGYPT GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. EGYPT GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. TURKEY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 197. TURKEY GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 198. TURKEY GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 199. TURKEY GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 200. TURKEY GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 201. TURKEY GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. TURKEY GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. ISRAEL GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. NORWAY GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 211. NORWAY GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 212. NORWAY GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 213. NORWAY GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 214. NORWAY GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 215. NORWAY GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. NORWAY GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. POLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 218. POLAND GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 219. POLAND GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 220. POLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 221. POLAND GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 222. POLAND GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. POLAND GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC GRAVES DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 239. CHINA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 240. CHINA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 241. CHINA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 242. CHINA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 243. CHINA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 244. CHINA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 245. CHINA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. INDIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 247. INDIA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 248. INDIA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 249. INDIA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 250. INDIA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 251. INDIA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 252. INDIA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. JAPAN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 254. JAPAN GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 255. JAPAN GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 256. JAPAN GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 257. JAPAN GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 258. JAPAN GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 259. JAPAN GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. THAILAND GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 282. THAILAND GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 283. THAILAND GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 284. THAILAND GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 285. THAILAND GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 286. THAILAND GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. THAILAND GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN GRAVES DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN GRAVES DISEASE MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN GRAVES DISEASE MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN GRAVES DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN GRAVES DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN GRAVES DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN GRAVES DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 323. GRAVES DISEASE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 324. GRAVES DISEASE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Graves Disease market report include:
  • Abbott Laboratories
  • AdvanceCor GmbH
  • Cadila Pharmaceuticals Limited
  • CORONA Remedies Limited
  • Daxia Healthcare Pvt Ltd.
  • Eris Lifesciences Ltd
  • F. Hoffmann-La Roche Ltd.
  • Immunovant, Inc. by Roivant Sciences Ltd.
  • LGM Pharma
  • Macleods Pharmaceuticals Ltd.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Salvavidas Pharmaceutical Pvt. Ltd.
  • Siemens Healthineers AG
  • Steris Healthcare Pvt Ltd
  • Sun Pharmaceutical Industries Ltd
  • Synmedic Laboratories by Dhanuka Laboratories Limited
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • Wellona Pharma

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 677.2 Million
Forecasted Market Value ( USD ) by 2030 $ 900.53 Million
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Graves' Disease (Overactive Thyroid) - Global Strategic Business Report - Product Image

Graves' Disease (Overactive Thyroid) - Global Strategic Business Report

  • Report
  • 386 Pages
  • Global
From
Graves' Orbitopathy- Pipeline Insight, 2025 - Product Image

Graves' Orbitopathy- Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Graves' Disease - Pipeline Insight, 2025 - Product Image

Graves' Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Carbimazole Market by Form, Application, Product Type, Distribution Channel - Global Forecast to 2030 - Product Image

Carbimazole Market by Form, Application, Product Type, Distribution Channel - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Global Thyroid Eye Disease Treatment Market (2025 Edition): Analysis By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), Route of Administration, Distribution Channel: Market Insights and Forecast (2021-2031) - Product Image

Global Thyroid Eye Disease Treatment Market (2025 Edition): Analysis By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), Route of Administration, Distribution Channel: Market Insights and Forecast (2021-2031)

  • Report
  • 238 Pages
  • Global
From

About the Graves Disease Market

Graves Disease is a type of autoimmune disorder that affects the thyroid gland. It is the most common cause of hyperthyroidism, a condition in which the thyroid produces too much of the hormone thyroxine. Symptoms of Graves Disease include weight loss, increased appetite, rapid heart rate, and bulging eyes. Treatment typically involves medications to reduce the production of thyroxine, as well as radioactive iodine therapy to destroy the thyroid gland. Allergy and Immunology is a medical specialty that focuses on the diagnosis and treatment of allergies and immune system disorders. Allergy and Immunology specialists are trained to diagnose and treat Graves Disease, as well as other autoimmune disorders. They may also provide advice on lifestyle changes to help manage the condition. Companies in the Graves Disease market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.